Rama Chellappa, PhD, John Hopkins University Bloomberg Distinguished Professor in electrical, computer, and biomedical engineering, and co-author of “Can We Trust AI?” looks at the promise of AI in health care and how we can best utilize this extraordinary tool to save lives and improve health equity.
Patient-administered healthcare is one of the fastest-growing segments in the medtech industry. When the patient becomes the operator, usability requirements are vastly different than those of trained clinicians, which elevates considerations in the design process.
Increased use of remote and telehealth programs, networked medical devices, and “smart” product storage come with their own inherent risks.
Keeping temperature-sensitive medical products within the required levels is vital in today’s world, especially as supply-chain issues are making transportation challenging. Monitoring equipment will ensure items stay safe as they move from the device manufacturer to consumer.
Growing pressure on the manufacturing industry from rising prices, new regulations and supply chain uncertainty have accelerated medtech’s digital transformation. COVID-19, in particular, has encouraged medical manufacturers to adopt more resilient and agile working practices. New technology can enable process changes and business strategies that help medical manufacturers become more flexible and responsive to changing…
Today’s health monitoring and management systems rely on wires and batteries, and often are not continuously connected to an alert and communication system for patients and doctors. Wireless power will empower medical device manufacturers to develop sophisticated, smart IoT systems that will improve patient care and patient lives.
Increased awareness during the COVID-19 crisis and public efforts to strengthen the development of healthcare technologies has boosted the smart medical devices sector.
RPM products with medical-grade sensors can play a dynamic role in developing personalized medicine.
The deal will strengthen Stryker’s portfolio of smart technologies in its joint replacement business and provide products that help physicians make data-driven decisions.
The agency is seeking solutions to rapidly address public health needs related to the pandemic.
